Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 15, 2017 09:15 ET | Source: Immuron Limited

Immuron Commences US Non-Deal Institutional Investor Roadshow

MELBOURNE, Australia, Aug. 15, 2017 (GLOBE NEWSWIRE) -- Australian microbiome biopharmaceutical company Immuron Limited (ASX:IMC) (NASDAQ:IMRN) is pleased to release to shareholders and investors...
August 09, 2017 08:30 ET | Source: Immuron Limited

Immuron Approved to Commence Clinical Study in C.Difficile Infection (CDI)

Key Highlights Final approval for key first in-human Clinical Study for CDI treatment, by Israeli Ministry of HealthAn estimated 28,000 patients die each year from CDI infections in the USA...
December 15, 2016 04:55 ET | Source: HiberGene Diagnostics Ltd

HiberGene Launches HG C. Difficile Test

DUBLIN, Ireland, Dec. 15, 2016 (GLOBE NEWSWIRE) -- HiberGene Diagnostics, a company focussed on applying molecular technology to the infectious disease segment of the diagnostics market, has...